McKesson (NYSE:MCK) Stock: Insider Francisco Fraga Sells 600 Shares

Key Points

• McKesson EVP Francisco Fraga sold 600 shares for $630,000 at an average price of $1,050, leaving him with 5,064 shares. The sale was made under a pre-arranged Rule 10b5-1 plan to cover tax withholding on vested equity awards.
• McKesson reported quarterly EPS of $11.68, beating the $10.72 consensus, and revenue of $110.96 billion, up 7.5% year over year and ahead of estimates.
• The company declared a quarterly dividend of $0.94 per share, equivalent to a 0.3% yield; analysts’ consensus rating was “Moderate Buy.”

McKesson Corporation (NYSE:MCK - Get Free Report) EVP Francisco Fraga sold 600 shares of the firm's stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $1,050.00, for a total transaction of $630,000.00. Following the completion of the sale, the executive vice president directly owned 5,064 shares in the company, valued at $5,317,200. This represents a 10.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Francisco Fraga also recently made the following trade(s):

• On Thursday, October 15th, Francisco Fraga sold 800 shares of McKesson stock. The stock was sold at an average price of $995.80, for a total transaction of $796,640.00.

McKesson Price Performance

MCK stock traded up $10.56 on Thursday, hitting $1,080.00. 839,263 shares of the company were exchanged, compared to its average volume of 917,913. The stock has a market capitalization of $125.92 billion, a price-to-earnings ratio of 28.98, a price-to-earnings-growth ratio of 1.99 and a beta of 0.27. McKesson Corporation has a twelve month low of $723.68 and a twelve month high of $1,121.50. The business's fifty day moving average is $931.17 and its two-hundred day moving average is $865.74.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, beating analysts' consensus estimates of $10.72 by $0.96. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company had revenue of $110.96 billion for the quarter, compared to analyst estimates of $109.90 billion. During the same quarter last year, the business earned $9.86 EPS. McKesson's revenue for the quarter was up 7.5% on a year-over-year basis. Equities research analysts expect that McKesson Corporation will post 44.71 earnings per share for the current year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be given a $0.94 dividend. This represents a $3.76 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, December 1st. McKesson's dividend payout ratio (DPR) is 10.06%.

Analyst Upgrades and Downgrades

MCK has been the subject of several research analyst reports. Evercore restated an "outperform" rating and set a $950.00 price target (down from $1,000.00) on shares of McKesson in a research note on Thursday, August 6th. Leerink Partners lifted their price objective on McKesson from $1,070.00 to $1,200.00 and gave the company an "outperform" rating in a research note on Thursday. Mizuho boosted their target price on McKesson from $905.00 to $1,020.00 and gave the stock a "neutral" rating in a report on Tuesday, October 20th. TD Cowen boosted their target price on McKesson from $989.00 to $1,006.00 and gave the stock a "buy" rating in a report on Thursday, August 6th. Finally, Wells Fargo & Company increased their target price on shares of McKesson from $812.00 to $933.00 and gave the stock an "equal weight" rating in a research report on Tuesday, August 11th. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, McKesson currently has a consensus rating of "Moderate Buy" and an average price target of $1,011.82.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson reported adjusted EPS of $11.68, ahead of analysts’ roughly $10.70–$10.72 estimates, while revenue of $110.96 billion topped expectations of $109.9 billion and grew about 7.5% year over year. MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
• Positive Sentiment: The company raised its fiscal 2027 adjusted EPS outlook to $45.60–$46.40. Management cited specialty distribution, higher prescription volumes and GLP-1 momentum as growth drivers. McKesson Corp (MCK) Q2 2027 Earnings Call Highlights
• Positive Sentiment: TD Cowen and Evercore ISI each raised their price target to $1,200, from $1,006 and $1,000, respectively—signaling improved analyst expectations after the results. TD Cowen Adjusts Price Target Evercore ISI Adjusts Price Target
• Neutral Sentiment: McKesson closed its $2.25 billion Precision Medicine Group acquisition, expanding its position in precision medicine. The deal offers growth potential, with execution and integration still to come. McKesson Outlook and Precision Medicine Deal
• Negative Sentiment: Some investors appeared cautious despite the earnings beat, with reports describing an after-hours stock dip. Earlier coverage also flagged branded-drug pricing pressure as a potential headwind. Q2 Earnings and Outlook

Hedge Funds Weigh In On McKesson

Institutional investors and hedge funds have recently bought and sold shares of the stock. DSG Capital Advisors LLC increased its holdings in shares of McKesson by 20.0% in the third quarter. DSG Capital Advisors LLC now owns 4,134 shares of the company's stock valued at $3,530,000 after purchasing an additional 690 shares during the last quarter. Northbridge Financial Group LLC grew its stake in McKesson by 2.1% in the 3rd quarter. Northbridge Financial Group LLC now owns 766 shares of the company's stock valued at $706,000 after buying an additional 16 shares during the last quarter. AMG National Trust Bank grew its stake in McKesson by 2.0% in the 3rd quarter. AMG National Trust Bank now owns 3,596 shares of the company's stock valued at $3,071,000 after buying an additional 69 shares during the last quarter. Keybank National Association OH grew its stake in McKesson by 4.5% in the 3rd quarter. Keybank National Association OH now owns 4,460 shares of the company's stock valued at $3,808,000 after buying an additional 192 shares during the last quarter. Finally, Cornerstone Wealth Management LLC bought a new position in McKesson in the 3rd quarter valued at about $256,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson's principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.